Navigation Links
Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
Date:9/10/2007

BASKING RIDGE, N.J., Sept. 10 /PRNewswire-FirstCall/ -- Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) announced that it raised $2,277,000 through the private placement of its equity securities. These securities have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration under such Act or an applicable exemption from the registration requirements. Millennium, through its wholly owned subsidiary, Millennium Biotechnologies, Inc., is now positioned to launch products into the P4 Healthcare oncology network and the U.S. and International sports markets.

The recently announced P4 Healthcare relationship is an unprecedented approach to nutrition in the medical markets. Many of the largest private oncology practices in the country will be preferentially offering RESURGEX(R) products to their patients, in their offices, beginning in Q4 of '07. In addition, the Resurgex line of products will be strategically marketed by P4 in its professional Caring4Cancer journal and informative website, http://www.caring4cancer.com

After several successful clinical trials, Millennium will launch its new sports product SURGEX(TM) into the U.S. and International sports markets in Q4 of '07. The response to the results of the trials as well as feedback on SURGEX(TM) from many professional strength and conditioning coaches and players, has been overwhelmingly positive, and sets the stage for a national and international launch.

About Millennium Biotechnologies, Inc.: Millennium Biotechnologies, Inc. is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. The company's flagship products, Resurgex(R), Resurgex Plus(R), and Resurgex Select(R), are designed to assist in reducing fatigue and oxidative stress, maintaining lean muscle and immune support in immunocompromi
'/>"/>

SOURCE Millennium Biotechnologies Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CPM Marketing Group, Announces Alliance for Healthcare Technology
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...NEAPOLIS, July 3 /- The Eniva Researc...g by the world-famous Linus Pauling,Micronutrient ...h,demonstrated the Eniva Health Supplement VIBE(R)...for human cells. This third party testing was,perf...o further identify,mechanisms by which the Eniva V...
(Date:7/3/2008)...SISSAUGA, ON, July 3 / Vaso...that it has implemented additional,restructuring p...iously,announced, the Company has been exploring s...cquisitions and mergers. In conjunction with this,...ve review of its VP,series of drugs, and has deter...
(Date:7/3/2008)... BRUNSWICK, N.J., July 3 /-...pany") (Amex: SNT ) announced today,that it has c...ance) to,supply Polyplus,s "in vivo-jetPEI" for sy...f siRNA against Factor 5A and a plasmid of the Fac...itive preclinical in vivo results,using its combin...
(Date:7/3/2008)...INE, Calif., July 3 /- Antigen Discov....), a leader in high throughput,antigen/biomarker ...ools,announced today that the Company was awarded...lergy and Infectious Diseases (NIAID) and the,Nati...million grant will,fund efforts to further develop...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2Vasogen Provides Corporate Update 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 2Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 3Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System 4Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development 2
... One certain consequence of the nearly $60 billion...te cleaning. The first bigwig out the door is Dr. ...acia,s research and development operations. Today,...ompanies, announced Ando as its new chief executiv...ent of Pharmacia is leaving Pfizer," Ando says. "T...
...tical qualities that separates good business execu...ision. The American Heritage Dictionary defines vi...ption, or intelligent foresight. Many people claim...ople dont have that ability. During the Internet d...ies. They talked an interesting game, but when the...
...ant to test a theory. In short, aspects of the eco...use the migration of technology-centric and savvy ...such as Silicon Valley and Boston to smaller commu...fusion into those areas of new blood, entrepreneur...lly) new capital, will inspire a revival of many c...
...The recent Chicago biotech festivals weren,t the...ly coming of age. , ,That same week, the Illinoi...cted as its new chairman Jim L. Tyree, vice presid...t Abbott Laboratories (not to be confused with ...se it means Abbott is stepping up to the plate to ...
Other Biology Technology:Pfizer-Pharmacia Fallout Gives Celltech A CEO 2Leadership is all about Vision 2Leadership is all about Vision 3The Milkweed Effect: Disseminating Technology to New Regions 2The Milkweed Effect: Disseminating Technology to New Regions 3The Milkweed Effect: Disseminating Technology to New Regions 4Abbott Executive Jim Tyree Takes IBIO Helm 2Abbott Executive Jim Tyree Takes IBIO Helm 3Abbott Executive Jim Tyree Takes IBIO Helm 4Abbott Executive Jim Tyree Takes IBIO Helm 5Abbott Executive Jim Tyree Takes IBIO Helm 6Abbott Executive Jim Tyree Takes IBIO Helm 7Abbott Executive Jim Tyree Takes IBIO Helm 8
(Date:7/3/2008)...f aging and live longer? New Saint Louis Universit... be a promising strategy. , Calorie restriction...rats and mice. While scientists do not know how ca...ents, one popular hypothesis is that it slows agin...e (T3), which then slows metabolism and tissue agi...
(Date:7/3/2008)... Endangered wild orangutan (Pongo spp.) population... than previously estimated, according to new findi...a scientist Dr. Serge Wich and other orangutan con...nal of Conservation . , , Conservation action e...the islands of Sumatra and Borneo, must be region-...
(Date:7/2/2008)...tanding in a greenhouse at the University of Rhode...appeared that something had gone terribly wrong. ...last February in hundreds of small pots were dead....,t surprised. That,s because the pots had been si...s, and few varieties of grass can put up with that...
(Date:7/2/2008)...d the U.K. have discovered that our own body not o... ingredient in marijuana (THC), but these play an... finding on "endocannabinoids" just published onli...sue of, The FASEB Journal could lead to new drug...dry skin, and even skin-related tumors. , "Our ...
Breaking Biology News(10 mins):Looking for the Founatain of Youth? Cut your calories, research suggests 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 2Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 3Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 4Great Ape Trust's Wich lead author of Oryx paper on continuing orangutan population declines 5Search for salt tolerant grasses aims to improve roadside plantings 2VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 1VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 2VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 3VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 4VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA 2291 to Reduce Vascular Inflammation 1152 5Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 1Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug 1147 2Springer launches Tropical Plant Biology 1792 1Springer launches Tropical Plant Biology 1792 2Despite efforts significant racial disparities in cancer therapy still exist 9139 1Despite efforts significant racial disparities in cancer therapy still exist 9139 2
... by predators, sea slugs defend themselves by ejec...ting of hydrogen peroxide, ammonia and several typ...a-based Center for Behavioral Neuroscience (CBN) h...ally inert chemicals stored separately in two glan...e edition of the Journal of Experimental Biology, ...
...ory students have discovered the antler of an Iris...an. , Although the exact age of the antler has ye...dicates that the elk (Megaloceros giganteus) lived...e open tundra landscape that was widespread in nor...e glaciers retreated northwards. , The students ...
...edical Institute researchers have discovered a vas...erns reproduction and controls the effects of repr...ir studies, the researchers found neural circuits ...s that control reproduction and brain areas that c...ules and those triggered by pheromones, chemical s...
...ith the potential to repair damaged heart muscle t...ew cartilage or skin . . . even reverse nerve dama... development of revolutionary medical treatments f...ems. , Up until now, however, stem cell research h...s by the rarity of the extraordinary cells themsel...
Other Biology News:Sea slug mixes chemical defense before firing at predators 2Students discover 11,000 year old remains of Irish Elk 2The brain is broadly wired for reproduction 2The brain is broadly wired for reproduction 3The brain is broadly wired for reproduction 4The brain is broadly wired for reproduction 5From one cell, many possible cures 2From one cell, many possible cures 3
...ector Sequencing Primer is designed for sequencing...s (Cat.# V2031, V2051, V2061). The primer hybridiz...25343, approximately 4050 base pairs upstream of t...rmine if an insert is cloned in-frame with the bio...
The versatile Zymo-Spin I-96 Plate can be used either in centrifuges or on vacuum manifolds for the large-scale (i.e., 96-well) purification of DNA and/or RNA. Its deep-well, durable polypropylene co
AdestaTM Tissue/Cell Preservation Medium Sterile / Non-sterile: Sterility Tested Endotoxin:
...he first all-inclusive collection of key procedure.... Methods developed by the leaders in Pichia expre...cols. This book will guide you from choosing the a...ruction and analysis, to production of your protei...
Biology Products: